Acutus Medical Inc (AFIB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Acutus Medical Inc (AFIB) has a cash flow conversion efficiency ratio of 0.350x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.06 Million) by net assets ($-11.59 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Acutus Medical Inc - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Acutus Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Acutus Medical Inc (AFIB) total liabilities for a breakdown of total debt and financial obligations.
Acutus Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Acutus Medical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
River and Mercantile UK Micro Cap Investment Company Ltd
LSE:RMMC
|
-0.007x |
|
Spectra Systems Corp
LSE:SPSY
|
-0.016x |
|
Teras Resources Inc
V:TRA
|
0.129x |
|
Geneuro SA
PA:GNRO
|
0.393x |
|
Ampli SA w upadlosci ukladowej
WAR:APL
|
0.049x |
|
Centurion Minerals Ltd
V:CTN
|
0.106x |
|
Vitality Products Inc
V:VPI
|
-0.023x |
|
Urbanimmersive Inc
V:UI
|
-0.002x |
Annual Cash Flow Conversion Efficiency for Acutus Medical Inc (2018–2024)
The table below shows the annual cash flow conversion efficiency of Acutus Medical Inc from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see Acutus Medical Inc market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-11.59 Million | $-31.66 Million | 2.731x | -96.20% |
| 2023-12-31 | $-879.00K | $-63.12 Million | 71.807x | +6435.10% |
| 2022-12-31 | $75.02 Million | $-85.03 Million | -1.133x | -20.22% |
| 2021-12-31 | $105.73 Million | $-99.68 Million | -0.943x | -40.13% |
| 2020-12-31 | $126.58 Million | $-85.17 Million | -0.673x | -371.38% |
| 2019-12-31 | $-225.81 Million | $-55.99 Million | 0.248x | -3.25% |
| 2018-12-31 | $-131.82 Million | $-33.78 Million | 0.256x | -- |
About Acutus Medical Inc
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well a… Read more